Perbedaan Niramas Utama Tbk. dan Merck Tbk.: Niramas Utama Tbk. diperdagangkan di Rp1.005 (kapitalisasi pasar 1,31 T, volume 24 jam 64,48 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb). Perbedaan utamanya: Merck Tbk. lebih besar dari sisi kapitalisasi pasar, dan Niramas Utama Tbk. lebih aktif diperdagangkan (64,48 jt vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| JELI | MERK | |
|---|---|---|
Kapitalisasi Pasar | 1,31 T | 1,7 T |
Volume | 64,48 jt | 37,6 rb |
Lot | 644,81 rb | 376 |
Perputaran | 65,83 M | 144,47 jt |
Harga Rata-rata | 1.020,91 | 3.842,23 |
Nilai Transaksi | 65,83 M | 144,47 jt |
Harga Ekuilibrium Indikatif | 1.005 | 3.840 |
Volume Ekuilibrium Indikatif | 24,22 rb | 7 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama
Selengkapnya di halaman JELI →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →